About
The company says he holds a Bachelor of Pharmaceutical Sciences from the University of Tokyo; its 2023 announcement names the Faculty of Pharmacy and states that he was born in 1962 in Shizuoka Prefecture. He led the US subsidiary OSI Pharmaceuticals as president and CEO from October 2010, then served as chief strategy officer, and later also as chief financial officer and chief business officer. Whoo also has pages for Julie Kim, president and CEO of Takeda, another Japanese drug maker, and Hiroki Totoki of Sony Group.
Whoo compiled this page from public sources: Astellas leadership page, Astellas press release via BioSpace, February 2023, The Shashi. It is not affiliated with or endorsed by Naoki Okamura. Are you Naoki Okamura? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
Representative Director, President and CEO — Astellas Pharma
April 2023 – Present
- Succeeded Kenji Yasukawa, who became chairman of the board
- Also chief financial officer from October 2019 and chief business officer from September 2021, until March 2022
Representative Director, Executive Vice President, Chief Strategy Officer — Astellas Pharma
June 2019 – March 2023
Senior Vice President and Chief Strategy Officer — Astellas Pharma Europe
April 2012
President and CEO — OSI Pharmaceuticals, Inc.
October 2010
Joined Yamanouchi Pharmaceutical (now Astellas Pharma)
April 1986
Education
Pharmaceutical Sciences — University of Tokyo
Bachelor, Faculty of Pharmacy